Treeline Biosciences Funding: $1.1B Raised, Series A (2025)
Treeline Biosciences is a Biotech company based in Watertown, Massachusetts. It has raised $1.1B in total funding. Latest round: Series A.
Treeline Biosciences funding overview
Treeline Biosciences is a Biotech company based in Watertown, Massachusetts. Treeline Biosciences has raised $1.1B in total disclosed funding. That places its disclosed total in over $1B. Its most recent disclosed round is a Series A announced in September 2025. The round record for Treeline Biosciences runs through 2025; nothing later has been disclosed. Investors on record include Arch Venture Partners, OrbiMed, GV, Access Industries, Ajax Health/Zeus, Casdin Capital and 7 others. 13 distinct backers are named across the disclosed rounds.
Frequently asked about Treeline Biosciences funding
How much has Treeline Biosciences raised?
Treeline Biosciences has raised $1.1B in total disclosed funding across the rounds on record.
Who has invested in Treeline Biosciences?
Arch Venture Partners, OrbiMed, GV, Access Industries, Ajax Health/Zeus, Casdin Capital are named among the investors backing Treeline Biosciences.
What was the latest Treeline Biosciences funding round?
The most recent disclosed round is a Series A, announced in September 2025.
Where is Treeline Biosciences based?
Treeline Biosciences is based in Watertown, Massachusetts.
What sector does Treeline Biosciences operate in?
Treeline Biosciences is tracked under Biotech from Watertown, Massachusetts, with $1.1B in disclosed funding.
When did Treeline Biosciences last raise?
The last disclosed Treeline Biosciences round closed in September 2025 at Series A.
Round data for Treeline Biosciences is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Watertown and backer lists below.
